Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
5.310
+0.120
+2.31%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Which stocks will surge next?
Unlock AI-picked Stocks
CorMedix Inc (CRMD)
Add to/Remove from a Portfolio
Add to Watchlist
After Hours
5.319
+0.009
+0.169%
19:50:04 - Real-time Data
- Volume: 312,826
- Bid/Ask: 0.000 / 0.000
- Day's Range: 5.090 - 5.330
Type:
Equity
Market:
United States
CorMedix
5.310
+0.120
+2.31%
- Discussions
- Recent Sentiments
- User Rankings
CRMD User Rankings
Bellow, users are ranked according to the performance of their sentiments for the CorMedix Inc stock.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Joshua Lauer | 1 | 1 | 1 | 100 | +97.69% |
| 2 | Lorraine Ry | 1 | 1 | 1 | 100 | +96.89% |
| 3 | Elijah Herrman | 1 | 1 | 1 | 100 | +96.09% |
| 4 | Marc Barberis | 1 | 1 | 1 | 100 | +78.5% |
| 5 | Tom Geldhof | 1 | 1 | 1 | 100 | +74.71% |
| 6 | Carlos Áaaaasssss | 1 | 1 | 1 | 100 | +72.87% |
| 7 | Luis Aguiar | 1 | 1 | 1 | 100 | +72.78% |
| 8 | yai banlao | 1 | 1 | 1 | 100 | +70.14% |
| 9 | John Motacek | 1 | 1 | 1 | 100 | +69.68% |
| 10 | Timothy LeMay | 1 | 1 | 1 | 100 | +68.95% |
| 11 | Diego Martinez | 1 | 1 | 1 | 100 | +66.92% |
| 12 | jm landaluce | 44 | 44 | 39 | 88.64 | +65.9% |
| 13 | luigi gualt | 1 | 1 | 1 | 100 | +65.32% |
| 14 | Borko Bacic | 1 | 1 | 1 | 100 | +63.82% |
| 15 | Fede López | 1 | 1 | 1 | 100 | +62.41% |
| 16 | Erik Boehm | 1 | 1 | 1 | 100 | +62.41% |
| 17 | Kenneth Goff | 1 | 1 | 1 | 100 | +60.07% |
| 18 | Olivier Boulogne | 1 | 1 | 1 | 100 | +57.61% |
| 19 | Daniel Batista | 5 | 5 | 2 | 40 | +50.74% |
| 20 | Mirco Ardito | 1 | 1 | 1 | 100 | +50.37% |
| 21 | Tamar Anderson | 1 | 1 | 1 | 100 | +48.19% |
| 22 | erik maguina | 1 | 1 | 1 | 100 | +32.39% |
| 23 | Hermann Albrecht | 2 | 2 | 2 | 100 | +27.15% |
| 24 | Blair Allen | 2 | 2 | 1 | 50 | +25.79% |
| 25 | mark wilson | 1 | 1 | 1 | 100 | +25.76% |
| 26 | Tim Skinner | 1 | 1 | 1 | 100 | +22.53% |
| 27 | Dharmesh Patel | 1 | 1 | 1 | 100 | +21.98% |
| 28 | Mike Wolfel | 1 | 1 | 1 | 100 | +18.92% |
| 29 | Timothy Viaene | 2 | 2 | 1 | 50 | +18.15% |
| 30 | LJ Waltman | 2 | 2 | 1 | 50 | +15.77% |
| 31 | Hermann Albrecht | 2 | 2 | 2 | 100 | +15.08% |
| 32 | Martina frias terres | 25 | 25 | 17 | 68 | +14.73% |
| 33 | Helena Mike | 2 | 2 | 1 | 50 | +11.77% |
| 34 | Jacob Willoughby | 1 | 1 | 1 | 100 | +10.47% |
| 35 | Kathy Bagnell | 1 | 1 | 1 | 100 | +9.45% |
| 36 | davide garulli | 2 | 2 | 1 | 50 | +8.29% |
| 37 | kera SDF | 1 | 1 | 1 | 100 | +8.24% |
| 38 | Diogo Gabriel | 1 | 1 | 1 | 100 | +7.87% |
| 39 | Moshe Malka | 1 | 1 | 1 | 100 | +7.16% |
| 40 | Rich Garay | 1 | 1 | 1 | 100 | +5.93% |
| 41 | Tasso Paps | 1 | 1 | 1 | 100 | +5.78% |
| 42 | Jason DeCarmen | 1 | 1 | 1 | 100 | +2.14% |
| 43 | Vyacheslav Veresov | 1 | 1 | 1 | 100 | +1.71% |
| 44 | vijendra singh | 1 | 1 | 1 | 100 | +1.14% |
| 45 | Raim McIntosh | 1 | 1 | 1 | 100 | +0.84% |
| 46 | Antonio garcia | 1 | 1 | 1 | 100 | +0.19% |
| 47 | djonivi ntchou | 1 | 1 | 0 | 0 | 0% |
| 48 | Arnaud DP | 4 | 4 | 0 | 0 | 0% |
| 49 | Yuxiang Xie | 1 | 1 | 0 | 0 | 0% |
| 50 | Keerti Anand | 1 | 1 | 0 | 0 | -0.48% |
Write your thoughts about CorMedix Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review